A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

For the study, investigators evaluated children aged 6 months to 5 years with moderate-to-severe atopic dermatitis who had been treated with either dupilumab or a placebo. Researchers compared ...

Atopic dermatitis affects an estimated 15% of children who experience persistent difficulty controlling pruritus or itch with associated scratching, further skin barrier damage, secondary skin ...

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the ...

Annual Meeting took place in Toronto, Canada, July 11-15, with our top coverage including the hot topics of combating ...

"Many children suffer from multiple allergic conditions at the same time, so knowing that dupilumab can be used to safely and effectively treat their atopic dermatitis whether or not they have ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Unspecified Respiratory Disorders.